Search results
Experimental NIH Antibody Protects Children From Malaria in Clinical Trial
SciTechDaily· 4 days agoA new study reports a single dose of a malaria antibody was 77% effective in protecting children in...
AstraZeneca admits Covishield jab raises TTS risk. Should you be worried?
Investing.com· 12 hours agoNew Delhi, April 30 (IANS) Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Napa Valley Register· 6 days agoFirst-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced colorectal cancer: Safety and efficacy results from a phase I study. First-in-class ...
NIH Reports Lower Dose of Mpox Vaccine is Safe and Generates Six-Week Antibody Response Equivalent...
Sierra Sun Times· 2 days agoA dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response...
Trial shows lower dose of mpox vaccine is safe, generates six-week antibody response equivalent to...
Medical Xpress· 23 hours agoThe Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN, sold as JYNNEOS) vaccine was made available to...
FDA approves Labcorp companion diagnostic for Pfizer gene therapy
Medical Device Network via Yahoo Finance· 5 hours agoLabcorp's nAbCyte cell-based neutralising antibody assay detects the presence of pre-existing...
Single Monoclonal Antibody Injection Protected Kids Against Malaria
MedPage Today· 4 days agoA single subcutaneous injection of an investigational monoclonalantibody was safe and effective in...
Experimental malaria monoclonal antibody protective in Malian children
Medical Xpress· 4 days ago"A long-acting monoclonal antibody delivered at a single health care visit that rapidly provides...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 17 hours agoCOPENHAGEN, Denmark; April 30, 2024 – Genmab A/S (Nasdaq: GMAB) and Pfizer Inc. (NYSE: PFE) announced today the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics ...
Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn
Pharmaceutical Technology via Yahoo Finance· 24 hours agoIn September 2023, Ono signed a drug discovery collaboration agreement with Adimab for the...